Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion

被引:31
作者
Silberstein, L
Davies, A
Kelsey, S
Foran, J
Murrell, C
D'Cruz, D
Vinnicombe, S
Norton, A
Cavenagh, J [1 ]
机构
[1] St Bartholomews Hosp, Dept Haematol Oncol, London EC1A 7BE, England
[2] St Bartholomews Hosp, Dept Rheumatol, London EC1A 7BE, England
[3] St Bartholomews Hosp, Dept Diagnost Imaging, London EC1A 7BE, England
[4] St Bartholomews Hosp, Dept Histopathol, London EC1A 7BE, England
关键词
polyserositis; pericardial effusion; constrictive pericarditis; myositis; graft-versus-host disease;
D O I
10.1038/sj.bmt.1702775
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The clinical features of chronic graft-versus-host disease (cGVHD) following a non-myeloablative peripheral blood stem cell (PBSC) transplant may differ from those that occur after a conventional allograft, We describe a man with Hodgkin's disease refractory to chemotherapy and radiotherapy who was transplanted from an HLA-identical brother, who developed cGVHD characterised, in particular, by polymyositis, polyserositis with a large pericardial effusion and constrictive pericarditis, 1 month after donor lymphocyte infusion for relapsed disease. Constrictive pericarditis has not been previously reported after a conventional allograft, and none of these features have been reported after a non-myeloablative transplant. The course of cGVHD necessitated potent immunosuppression leading to the presumed loss of graft-versus-lymphoma (GVL) effect.
引用
收藏
页码:231 / 233
页数:3
相关论文
共 10 条
[1]   Mini-allografts: ongoing trials in humans [J].
Carella, AM ;
Champlin, R ;
Slavin, S ;
McSweeney, P ;
Storb, R .
BONE MARROW TRANSPLANTATION, 2000, 25 (04) :345-350
[2]   Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].
Collins, RH ;
Shpilberg, O ;
Drobyski, WR ;
Porter, DL ;
Giralt, S ;
Champlin, R ;
Goodman, SA ;
Wolff, SN ;
Hu, W ;
Verfaillie, C ;
List, A ;
Dalton, W ;
Ognoskie, N ;
Chetrit, A ;
Antin, JH ;
Nemunaitis, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444
[3]  
Dazzi F, 1998, BLOOD, V92, p653A
[4]  
McSweeney P, 1999, BLOOD, V94, p393A
[5]  
McSweeney P A, 1999, Biol Blood Marrow Transplant, V5, P192, DOI 10.1053/bbmt.1999.v5.pm10465099
[6]  
PARKER M, 1997, CURR OPIN RHEUMATOL, V9, P513
[7]  
Spitzer TR, 1998, BLOOD, V92, p519A
[8]   Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation [J].
Sykes, M ;
Preffer, F ;
McAfee, S ;
Saidman, SL ;
Weymouth, D ;
Andrews, DM ;
Colby, C ;
Sackstein, R ;
Sachs, DH ;
Spitzer, TR .
LANCET, 1999, 353 (9166) :1755-1759
[9]  
Sykes M, 1998, BLOOD, V92, p520A
[10]   Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation [J].
Toren, A ;
Nagler, A .
BONE MARROW TRANSPLANTATION, 1997, 20 (09) :805-807